Connection
Alvaro Martinez-Camacho to Treatment Outcome
This is a "connection" page, showing publications Alvaro Martinez-Camacho has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.148 |
|
|
|
-
Bryant A, Kalra A, Truesdale A, Pyle L, Martinez-Camacho A. Favorable Sustained Virologic Response Rates Using Direct-Acting Antiviral Therapies at a Large Safety-Net Hospital. J Health Care Poor Underserved. 2020; 31(3):1213-1227.
Score: 0.066
-
Nordstrom EM, Keniston A, Baouchi F, Martinez-Camacho A. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety. Eur J Gastroenterol Hepatol. 2017 Jan; 29(1):10-16.
Score: 0.053
-
Ismail MS, Hassan M, Martinez-Camacho A, May SB, Goss JA, Kanwal F, Jalal PK. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int. 2020 08; 33(8):925-935.
Score: 0.017
-
Fortune BE, Martinez-Camacho A, Kreidler S, Gralla J, Everson GT. Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation. Transpl Int. 2015 Aug; 28(8):980-9.
Score: 0.012